ETR
52
3
AN
52
2
CSX
50
2
DHI
40
3
SPG
53
2
MU
79
3
RF
63
2
URBN
54
2
TROW
61
2
TSN
47
3
MCD
46
4
AAPL
55
2
PHM
43
2
NEM
69
-2
SIG
52
2
PX
55
2
GS
78
2
O
35
4
EL
59
-2
ADM
47
2
ETR
52
3
AN
52
2
CSX
50
2
DHI
40
3
SPG
53
2
MU
79
3
RF
63
2
URBN
54
2
TROW
61
2
TSN
47
3
MCD
46
4
AAPL
55
2
PHM
43
2
NEM
69
-2
SIG
52
2
PX
55
2
GS
78
2
O
35
4
EL
59
-2
ADM
47
2
Financhill
Back

ProShares Ultra Dow30 Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
79

DDM
ProShares Ultra Dow30

Last Price:
$58.53
Seasonality Move:
1.13%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
79
ProShares Ultra Dow30 (DDM) is a Buy

Is ProShares Ultra Dow30 a Buy, Sell or Hold?

  • The current ProShares Ultra Dow30 [DDM] share price is $58.44. The Score for DDM is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
  • DDM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DDM Stock Price Chart

What is ProShares Ultra Dow30's stock price today?

  • The ProShares Ultra Dow30 share price today is $58.44
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DDM is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

DDM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.75 Buy
Relative Strength Index (14 RSI): 62.03 Buy
Chaikin Money Flow: 139759 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.09 - 57.91) Buy
Bollinger Bands (100): (51.27 - 56.17) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

DDM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.54 Buy
20-day SMA: 56.83 Buy
50-day SMA: 55.5 Buy
200-day SMA: 49.59 Buy
8-day EMA: 57.52 Buy
20-day EMA: 56.81 Buy
50-day EMA: 55.56 Buy
200-day EMA: 51.46 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

ProShares Ultra Dow30 Earnings Growth & DDM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

ProShares Ultra Dow30 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):